Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 2
2006 4
2007 1
2008 5
2009 5
2010 11
2011 10
2012 7
2013 9
2014 8
2015 10
2016 10
2017 9
2018 10
2019 2
2020 8
2021 12
2022 10
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
Correlation between Topographic Vessel Density and Retinal Thickness Changes in Patients with Diabetic Macular Edema Treated with Anti-VEGF Therapy: Is It a Suitable OCTA Biomarker?
Santamaría J, Caminal JM, Cobos E, Biarnes M, Rodriguez-Leor R, Morwani R, García-Mendieta M, Lorenzo D, García-Bru P, Arias L. Santamaría J, et al. Among authors: arias l. J Pers Med. 2023 Dec 16;13(12):1718. doi: 10.3390/jpm13121718. J Pers Med. 2023. PMID: 38138945 Free PMC article.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
The First Latin American Consensus on Superficial and Perforating Venous Mapping.
Bottini O, Rodriguez Santos F, Boroda A, Arias F, Calcina D, Agüero Wagner C, Grillo L, Morales Bazurto M, Santiago F, Nigro J, Morales M, Ferreyra M, Perea Ansinelli A, Diaz M, Segura J, Mazzurco M, Diez G, Halusch E, Ovelar J, Parrotta L, Fernandez J, Avramovic M, Ríos J, Esposito A, Alfonso H, Desjardins E, Arias L, Joviliano E, Toledo DE Aguiar E, Barreto Dos Santos J, Orrego A, Bombín J, Pizarro I, Cabezas J, Manosalvas R, Villota V, Rodriguez L, Martínez Granados A, Mérida J, García Bernard D, Serralde J, Vega Rasgado F, Teixeira E, Filizzola R, Corbeta R, Benito R, Chunga Prieto J, Rivera T, Volpi M, Sarutte S, Ortiz P, Prego A, Navas H, Alberti T, Guglielmone D, Mejía R, Simkin C, Intriago E, Bercovich J. Bottini O, et al. Among authors: arias l. Int Angiol. 2023 Feb;42(1):45-58. doi: 10.23736/S0392-9590.23.04991-X. Int Angiol. 2023. PMID: 36892521 Free article.
129 results